Evid Invest
Who owns ENGNWhat ENGN owns — n/a

Who owns enGene Therapeutics Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ENGN from SEC Form 13F filings across 58 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 58 institutions disclosed 37.8M shares of enGene Therapeutics Inc. worth $75.6M — about 54.2% of shares outstanding; the largest disclosed holder is BML Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

58

13F holders

$75.6M

value, 2026 filers

54.2%

of shares outstanding (37.8M sh)

17

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ENGN's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BML Capital Management, LLC6.7M$13.3M7.1%9.6%0.0%
2Siren, L.L.C.6.3M$12.5M0.3%9%0.0%
3ACORN CAPITAL ADVISORS, LLC3.8M$7.6M2.1%5.5%+199.8%
4PERCEPTIVE ADVISORS LLC3.5M$7.0M0.1%5%-27.8%
5EVENTIDE ASSET MANAGEMENT, LLCNEW3.4M$6.8M0.1%4.9%new
6Nextech Invest Ltd.2.3M$4.6M0.2%3.3%0.0%
7Vestal Point Capital, LP1.7M$3.3M0.1%2.4%-0.1%
8ADAR1 Capital Management, LLC1.3M$2.7M0.1%1.9%-36.8%
9TWO SIGMA INVESTMENTS, LP1.3M$2.6M0.0%1.9%+685.2%
10RENAISSANCE TECHNOLOGIES LLC1.1M$2.3M0.0%1.6%+36.7%
11Peapod Lane Capital LLC1.0M$2.1M1.5%1.5%-5.8%
12SR ONE CAPITAL MANAGEMENT, LPNEW747,750$1.5M0.1%1.1%new
13Aldebaran Capital, LLCNEW657,319$1.3M0.9%0.9%new
14FLPUTNAM INVESTMENT MANAGEMENT CONEW556,121$1.1M0.0%0.8%new
15Kynam Capital Management, LP457,855$915,7100.1%0.7%0.0%
16CITADEL ADVISORS LLC444,471$888,9420.0%0.6%-38.1%
17Squarepoint Ops LLC299,747$599,4940.0%0.4%+39.2%
18JANE STREET GROUP, LLC291,730$583,4600.0%0.4%-23.7%
19Rangeley Capital, LLC287,898$575,7960.8%0.4%-5.6%
20MILLENNIUM MANAGEMENT LLC181,619$363,2380.0%0.3%-81.2%
21D. E. Shaw & Co., Inc.NEW170,408$340,8160.0%0.2%new
22Privium Fund Management B.V.170,000$340,0000.1%0.2%0.0%
23GSA CAPITAL PARTNERS LLP127,975$256,0000.0%0.2%+242.7%
24XTX Topco Ltd117,582$235,1640.0%0.2%-22.3%
25Quadrature Capital Ltd100,069$200,1380.0%0.1%-58.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.